Paul Tudor Jones Arcturus Therapeutics Holdings Inc. Transaction History

Tudor Investment Corp Et Al

  • $26.8 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$34.2 - $47.56 $195,316 - $271,615
-5,711 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$27.88 - $58.25 $159,222 - $332,665
5,711 New
5,711 $273,000
Q3 2020

Nov 16, 2020
SELL
$37.49 - $63.19 $162,931 - $274,623
-4,346 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$12.66 - $58.27 $55,020 - $253,241
4,346 New
4,346 $203,000

Others Institutions Holding ARCT

# of Institutions
179
Shares Held
25.6M
Call Options Held
195K
Put Options Held
133K
View Full List

About Arcturus Therapeutics Holdings Inc.

ARCT Quotes by TradingView
  • Ticker ARCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,576,400
  • Market Cap $411M
  • Description
  • Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...
More about ARCT
Track Paul Tudor Jones's Portfolio

Track Paul Tudor Jones Portfolio

Follow Paul Tudor Jones (Tudor Investment Corp Et Al) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email